Results 171 to 180 of about 95,782 (307)

Isoniazid Allergy [PDF]

BMJ, 1957
openaire   +2 more sources

A Pediatric Case of Severe Atopic Dermatitis on Dupilumab Treatment and Pulmonary Tuberculosis

Pediatric Dermatology, EarlyView.
Maria Efenesia Baffa, Leila Bianchi, Elisabetta Venturini, Nicola Pimpinelli, Samantha Berti   +4 more
wiley   +1 more source

Integrating Genetic and Single‐Cell Genomic Data to Reveal Brain Cell‐Specific Regulation of Attention‐Deficit/Hyperactivity Disorder Risk in the Prefrontal Cortex

Brain and Behavior, Volume 15, Issue 7, July 2025.
This study uncovers causal associations between specific brain cells in the prefrontal cortex and ADHD risk through single‐cell eQTL MR and Bayesian analyses, advancing our understanding of ADHD's neurobiology. Our findings highlight novel therapeutic targets, paving the way for new treatment strategies in ADHD management.
Jiawei Gui, Ziyi Xia, Keqi Wan, Xiangli Dong, Weiming Sun   +4 more
wiley   +1 more source

Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017- 2022. [PDF]

BMC Infect Dis
Kabugo J, Sande OJ, Kabahita JM, Namutebi J, Mujuni D, Oundo HR, Kisakye D, Batte DN, Joloba M, Mboowa G.   +9 more
europepmc   +1 more source

SOME ASPECTS OF VIRULENCE OF ISONIAZID-RESISTANT TUBERCLE BACILLI

, 1955
KOOMI KANAI, Hiroshi Takahashi, Shigeru Katsuyama, Ken Yanagisawa   +3 more
openalex   +2 more sources

EFFECT OF ISONIAZID ON THE INCORPORATION OF SOME RADIOACTIVE SUBSTANCES INTO THE CELLULAR FRACTIONS OF A STRAIN OF MYCOBACTERIUM [PDF]

, 1964
Michio Tsukamura, Shoji Mizuno, S Tsukamura   +2 more
openalex   +1 more source

Lupus Vulgaris on Face: A Case Report From Rural Nepal

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Lupus vulgaris (LV), the most common form of cutaneous tuberculosis, results from Mycobacterium tuberculosis infection via hematogenous, lymphatic, or direct transmission in individuals with moderate immunity and high tuberculin sensitivity. It predominantly affects females, constituting 1%–2% of extrapulmonary tuberculosis cases, with facial ...
Sabin Kandel, Nikita Shah, Aayush Bist
wiley   +1 more source

Development and optimization of an injectable in-situ gel system for sustained release of anti-tuberculosis drugs. [PDF]

Sci Rep
Balu P, Srikanth S, Gnandhas DP, Durai RD, Ulaganathan V, B Narayanan VH.   +5 more
europepmc   +1 more source

On the Mechanism of Acquisition of Streptomycin and Isoniazid-resistance of Mycobacterium tuberculosis var. hominis Strain H37Rv

, 1957
Sadami Tanaka
openalex   +2 more sources

Is Mycobacterial InhA a Suitable Target for Rational Drug Design?

ChemMedChem, Volume 20, Issue 13, July 1, 2025.
InhA is the target of isoniazid, a first‐line antituberculosis drug. Isoniazid is, in fact, a prodrug that needs to be activated. Researchers are trying to develop direct inhibitors of InhA. This includes the resolution of crystallographic structures. The Protein Data Bank contains over a hundred InhA structures.
Julien Rizet, Laurent Maveyraud, David Rengel, Valérie Guillet, Gabriel Publicola, Frédéric Rodriguez, Christian Lherbet, Lionel Mourey   +7 more
wiley   +1 more source